Stock Market News — November 06, 2026 — Midday Update — Last 12 Hours (Pacific Time)
Executive Summary
Markets are staging a partial but meaningful recovery Friday after Thursday's historic AI-driven rout wiped $2.5 trillion off the Nasdaq — its worst single day since 2020 — following the U.S. midterm "blue wave" and fears of tighter AI regulation under a new Democratic Congress. Chip stocks are leading the rebound, with AMD, Lam Research, Intel, and ASML all surging sharply, though the bounce remains incomplete and rate-hike fears linger after a stronger-than-expected October jobs report. Meanwhile, Tesla confirmed it will wind down Cybertruck production, Fox completed its $22 billion Roku acquisition, and Eli Lilly struck a direct partnership with Hims & Hers for obesity drugs — adding corporate dealmaking color to an otherwise macro-dominated session.
Sentiment Breakdown
| Sentiment | Count | Percentage |
|---|---|---|
| 🟢 Bullish | 78 | 35% |
| 🔴 Bearish | 112 | 50% |
| 🟡 Neutral | 32 | 15% |
Net Sentiment: Bearish-leaning. Despite Friday's partial rebound in U.S. tech, the broader picture — European markets closing sharply lower, Japan entering bear market territory, KOSPI down 12% on the week, and macro/regulatory headwinds from the Democratic sweep — keeps overall tone decidedly cautious.
Top Market-Moving Headlines
🔴 Macro/Markets | Investors wipe $2.5 trillion off Nasdaq after blue wave prompts AI fears
Market Impact: Thursday's selloff was the Nasdaq's worst day since 2020, with the Nasdaq 100 falling 6.4% and the S&P 500 also hit hard. The Democratic midterm sweep sparked fears of aggressive AI regulation and scrutiny of data center spending.
🟢 Sector Recovery | Nasdaq rebounds as chip stocks recover from steep losses
Market Impact: U.S. chip and AI-linked names staged a broad Friday bounce, with AMD +9.9%, Lam Research +10.8%, Intel +6.4%, ASML +5.0%, and Marvell +6.7% among the leaders. The rebound is partial — rate-hike fears from strong payrolls are capping gains.
🔴 Macro/Policy | Democrats planning flood of AI bills when they take control of Congress
Market Impact: Incoming Democratic majority is preparing sweeping AI legislation, directly threatening the regulatory environment for Big Tech and AI infrastructure companies. This is the core catalyst behind Thursday's rout and ongoing uncertainty.
🔴 Autos | Tesla to pull the plug on Cybertruck after years of poor sales
Market Impact: Tesla confirmed it will wind down Cybertruck production at its Texas Gigafactory, with Musk shifting focus to robotaxis. Despite the news, TSLA stock rallied 4.3% to ~$358–$359, suggesting markets view the pivot as strategically positive.
🟢 Healthcare/Pharma | Hims & Hers stock climbs 6.3% on direct partnership with Eli Lilly for obesity drugs
Market Impact: Eli Lilly will sell obesity drugs directly through the Hims & Hers platform — a significant distribution deal that validates the telehealth model and expands GLP-1 access.
🟢 M&A/Media | Fox completes $22 billion Roku deal to expand digital reach
Market Impact: Fox Corp closed its $22 billion acquisition of Roku, making a major strategic bet on streaming distribution. One of the largest media deals of the year, now finalized.
🟢 M&A/Industrials | AkzoNobel and Axalta gain conditional EU antitrust approval for $25 billion merger
Market Impact: The Dulux/Axalta paint mega-merger clears a critical regulatory hurdle in Europe, paving the way for one of the largest specialty chemicals combinations in recent memory.
🔴 Japan/Asia | Japan's Nikkei enters bear market as AI rout sends chip shares into sharp retreat
Market Impact: The Nikkei 225 fell 6.04% Friday and is now down more than 20% from its June record high, entering official bear market territory. South Korea's KOSPI fell 12% on the week per Goldman Sachs.
🟢 Pharma | Moderna shares surge ~10% on earnings beat and raised revenue outlook
Market Impact: Moderna significantly beat Q3 earnings expectations and raised its full-year revenue forecast on strong international COVID vaccine demand — a rare bright spot in an otherwise turbulent session.
🟢 Travel/Leisure | Airbnb rises more than 10% on upbeat outlook, bucking broader industry caution
Market Impact: Airbnb raised its full-year revenue guidance, sending shares up more than 10% and standing out as one of the strongest earnings-driven movers of the day.
🔴 Healthcare | Globus Medical stock plunges 12.5% to fresh 52-week low
Market Impact: Shares hit $71.26, a new 52-week low, after disappointing results. No specific earnings detail provided beyond the price action.
🔴 Software | Atlassian tumbles ~16% as cautious outlook offsets strong quarterly beat
Market Impact: Despite beating Q1 results, Atlassian's weaker subscription growth guidance spooked investors, making it one of the session's worst-performing software names.
🟢 Semiconductors/M&A | Alphabet takes $548 million stake in Qualcomm in data center push
Market Impact: Alphabet disclosed a nearly $548 million stake in longtime partner Qualcomm, signaling deeper integration between the two companies on AI/data center hardware.
🔴 Biotech | Inovio stock tumbles 25% on $75 million share offering
Market Impact: A dilutive equity raise sent Inovio shares down 25% — a sharp reminder of the funding pressures facing smaller biotech names.
🔴 Biotech | Natera stock tumbles 15.3% in pre-market
Market Impact: The genetic testing company hit $308 in pre-open trading after posting results that disappointed investors, one of the steeper biotech declines of the session.
🟢 Space/Defense | Firefly Aerospace surges ~15% on $1.3 billion engine deal with AST SpaceMobile
Market Impact: Firefly will supply core engines for AST SpaceMobile's new "Blacklift" rocket under a three-year agreement — a landmark commercial space deal boosting both names.
🟢 Software/M&A | Extreme Networks jumps ~15% on report company is exploring a sale
Market Impact: A Reuters exclusive that Extreme Networks is exploring a sale sent shares surging, making it one of the day's top M&A-driven movers in networking software.
🔴 Crypto/Finance | Binance $6.3 billion heist to prompt closer scrutiny by insurers
Market Impact: Last week's massive Binance hack is now rippling into the insurance sector, with underwriters reassessing crypto exposure — a systemic risk signal for the digital asset industry.
🟡 Macro/Jobs | S&P 500 futures pare gains after October non-farm payrolls data
Market Impact: A stronger-than-expected October jobs report reinforced expectations for further Fed rate hikes, capping the equity rebound and adding a second macro headwind alongside AI regulation fears.
🔴 Trump Media | Trump Media investors lost $2.2 billion while Trump holds $460 million stake
Market Impact: A stark illustration of the asymmetric risk in Trump Media — retail investors have absorbed the bulk of losses while the former president's stake remains largely intact.
Tickers in Focus
| Ticker | Price / Change | Context |
|---|---|---|
| TSLA | ~$358–$359 / +4.3–4.5% | Cybertruck wind-down confirmed; stock rallies on robotaxi pivot |
| AMD | +9.9% | Sharp rebound from Thursday's AI-driven selloff |
| LRCX | +10.8% | Lam Research leads semiconductor equipment bounce |
| INTC | ~$55.60 / +6.4% | Intel surges as beaten-down semis recover |
| ASML | +5.0% | ASML ADR rebounds with broader chip sector |
| NVDA | -9.3% Thursday; rebounding Friday | Worst day since Jan 2025; oversold setup being watched |
| AVGO | ~$294.93 / +1.2% | Broadcom partial recovery |
| PLTR | ~$160.72–$161.69 / +3.7–4.3% | Palantir relief bounce after AI rout |
| HIMS | +6.3% | Eli Lilly direct obesity drug partnership |
| MRVL | +6.7% | Marvell rebounds with AI chip names |
| AMAT | +5.5% | Applied Materials bounces from severe Thursday selloff |
| KLA | +7.2% | KLA dip-buyers return to semiconductor equipment |
| MRNA | +8.5–10% | Moderna earnings beat; raised revenue outlook |
| ABNB | ~$189.50 / +10–11.4% | Airbnb raised full-year guidance |
| EXTR | ~$24.12 / +14.6–15.3% | Extreme Networks exploring sale |
| TEAM | -15.8–16% | Atlassian cautious outlook despite earnings beat |
| GLOB (Globus Medical) | ~$71.26 / -12.5% | Fresh 52-week low after disappointing results |
| INO | -25% | Inovio dilutive $75M share offering |
| NTRA | ~$308 / -15.3% | Natera pre-market tumble on earnings miss |
| FFLY (Firefly Aerospace) | +13–15.7% | $1.3B engine deal with AST SpaceMobile |
| ASTS | +2.5% | AST SpaceMobile unveils own rocket development |
| SITM | +16% | SiTime upgraded to Buy by Seaport after earnings dip |
| UI (Ubiquiti) | +16.9% | Landmark fiscal Q1 results |
| CGON (CG Oncology) | +19.7% | Strong Q3 results |
| RVMD (Revolution Medicines) | +7.0% | Continued momentum from blowout earnings |
| LPTH (LightPath) | +8.5% | Completed sale of China subsidiary |
| XE (X Energy) | +8.4% | Extended Fluor partnership for Washington SMR |
| OKLO | +12.8% | Advanced nuclear results beat |
| IREN | +18.1% | Strong fiscal Q1 2027 results |
| JFROG | +25.3% | Standout software supply chain earnings |
| IONQ | +7.7% | Strongest quarterly results in company history |
| CLOUD (Cloudflare) | +12.6% | Sweeping beat across all major metrics |
| UA (Under Armour) | -11.3% | Cut annual gross margin target; broad weakness flagged |
| CHTR (Charter Communications) | -6.6% | Q3 2026 results disappointed |
| LYFT | ~$16.66 / -6.6% | Ride-hailing results missed expectations |
| YELP | -6.6% | Q3 results disappointed |
| AXON | -9.8% | Q3 results missed despite strong business |
| DXCM (Dentsply Sirona) | -13.0% | Q3 2026 earnings miss |
| MNST (Monster Beverage) | ~$46.04 / -3.7% | Q3 2026 results missed |
| WMT | ~$124.39 / -2.6% | Underperforming broader market |
| MCHP (Microchip Technology) | -10.3% | Fiscal Q2 2027 earnings disappointed |
| GOOGL (Alphabet) | — | Disclosed $548M Qualcomm stake |
| QCOM | ~$164.20 / +4.8% | Qualcomm rebounds; Alphabet stake disclosed |
| TSM | Rising | Report of potential expansion into advanced memory for Nvidia |
| FOX/ROKU | — | Fox completed $22B Roku acquisition |
| HUYA (Humana) | Raised forecast | Lower medical costs drive full-year upgrade |
| DJT (Trump Media) | — | Investors lost $2.2B; Trump holds $460M stake |
| SPCX (SpaceX) | ~$131.52 / +6.39% | Deutsche Bank recommends buying after midterm selloff |
| NEBIUS | +10.1% | Rebounds from Thursday's losses |
| SAND (SanDisk) | +7.7% | Memory chip sector recovery |
| DELL | ~$341.39 / +7.7% | Sharp rebound in AI infrastructure names |
| BE (Bloom Energy) | +7.0% | Rebounds from prior session losses |
| CRWV (CoreWeave) | ~$45.73 / +4.7% | Bouncing from 52-week low |
| LUMN (Lumentum) | +7.9% | Broad semiconductor/AI rebound |
| TMDX (TransMedics) | +14.4% | Record quarterly results |
| YARW (Yarrow Bioscience) | +4.3% | Guggenheim initiates at Buy for Graves' disease potential |
| TWLV (Twenty One Capital) | Options imply ±3.4% | Earnings due Nov. 13 |
| STRV (Strive Inc.) | Options imply ±10% | Earnings today |
| IMVX (Immunome) | Options imply ±9.4% | Earnings due Nov. 13 |
| HUBG (Hub Group) | Options imply ±2.2% | Earnings due Nov. 13 |
| SEI (Solaris Energy) | Upgraded to Strong Buy | Raymond James sees tactical entry after selloff |
| TWLO (Terawulf) | +10.8% | Q3 2026 results beat expectations |
| FIVE9 | ~$28.44 / -16.7% | Cloud contact center results missed badly |
| GRND (Grindr) | ~$13.52 / -0.9% | Q3 2026 earnings in line but soft |
| AKMO (Akamai) | +5.0% | Q3 2026 results beat expectations |
| DOXI (Doximity) | -3.6% | Fiscal Q2 2027 results disappointed |
| MAT (Mattel) | ~$14.11 / -5.8% | Mixed Q3 results |
| HAZO (Halozyme) | -8.1% | Q3 results disappointed |
| AFRM (Affirm) | ~$68.32 / -1.9% | Q1 FY2027 results mixed |
| GH (Guardant Health) | -5.5% | Q3 precision oncology results missed |
| WYNN | -1.2% | Q3 luxury casino results soft |
| LVN (Live Nation) | -2.8% | Profit-taking after recent run |
| EOG | +1.8% | Blowout Q3 results |
| VISTR (Vistra) | +5.7% | Strong Q3 2026 results |
| NKLA (Nebius) | +10.1% | See above |
| GMAB (Genmab) | -3–4.9% | Q3 revenue slightly missed; Moody's revised outlook to positive |
| CLMB (Climb Bio) | Maintained Outperform | Wedbush raises price target |
Market Implications
The AI regulation risk is now the dominant macro variable. Thursday's $2.5 trillion Nasdaq wipeout — triggered by the Democratic midterm sweep and the prospect of sweeping AI legislation — has fundamentally repriced the regulatory risk premium for the sector. Friday's bounce is encouraging but incomplete, and with Democrats explicitly planning a "flood of AI bills," the overhang isn't going away. Investors should expect elevated volatility in AI infrastructure, data center, and semiconductor names heading into next week, particularly as U.S. inflation data is also on the calendar.
The jobs report adds a second headwind. A stronger-than-expected October non-farm payrolls print reinforced Fed rate-hike expectations, causing S&P 500 futures to pare gains mid-session. This creates a difficult dual pressure for growth stocks: tighter regulation on one side, tighter monetary policy on the other. Money market fund inflows hit a six-month high this week — a clear signal that institutional capital is rotating defensively.
Earnings season is delivering sharp bifurcation. The gap between winners and losers this reporting cycle is extreme: Airbnb +10%, JFrog +25%, Cloudflare +12%, IREN +18% on the upside — versus Atlassian -16%, Five9 -17%, Natera -15%, Inovio -25% on the downside. This dispersion rewards stock-pickers and punishes passive exposure to growth baskets. Next week's inflation print and continued earnings flow (Immunome, Hub Group, Twenty One Capital) will be key catalysts to watch.
Key Takeaways
- 🔴 Nasdaq/AI Rout — Thursday's 6.4% Nasdaq 100 drop was the worst since 2020; Friday's bounce is real but partial, and regulatory risk remains elevated.
- 🔴 Democratic AI Legislation — Incoming Congress is planning sweeping AI bills; this is the structural overhang that triggered the selloff and won't resolve quickly.
- 🟢 Chip Rebound — AMD (+9.9%), Lam Research (+10.8%), Intel (+6.4%), ASML (+5.0%) all staged sharp bounces — dip-buyers are active but conviction is cautious.
- 🔴 NVDA — Down 9.3% Thursday (worst day since January 2025); Friday rebound underway but oversold conditions bear watching.
- 🔴 TSLA/Cybertruck — Production wind-down confirmed; stock paradoxically rallied ~4.3% as markets view the robotaxi pivot as strategically sound.
- 🟢 HIMS/Eli Lilly — Direct obesity drug distribution deal is a meaningful validation of the telehealth model and GLP-1 market expansion.
- 🟢 FOX/ROKU — $22 billion acquisition completed; Fox makes a definitive streaming bet.
- 🟢 AkzoNobel/Axalta — $25 billion paint merger clears EU conditional approval; deal on track.
- 🟢 MRNA — Earnings beat and raised revenue guidance; strong international COVID vaccine demand is the driver.
- 🟢 ABNB — Raised full-year guidance; +10%+ move makes it one of the session's standout earnings winners.
- 🔴 Japan Nikkei — Entered bear market territory (down 20%+ from June highs); KOSPI fell 12% on the week — Asia is absorbing the AI rout harder than the U.S.
- 🔴 TEAM (Atlassian) — Beat earnings but cautious subscription growth outlook sent shares down ~16%; guidance matters more than beats right now.
- 🟢 FFLY (Firefly Aerospace) — $1.3 billion engine deal with AST SpaceMobile is a landmark commercial space contract.
- 🟢 EXTR (Extreme Networks) — M&A speculation (+15%) shows deal premium is alive even in a volatile tape.
- 🔴 INO (Inovio) — 25% drop on $75M dilutive offering is a cautionary tale for small-cap biotech funding risk.
- 🟡 Jobs Data — Stronger-than-expected October payrolls are capping the equity rebound by reinforcing Fed rate-hike expectations.
- 🔴 Binance Hack — $6.3 billion heist is prompting insurance sector reassessment of crypto exposure — systemic risk signal.
- 🟡 Anthropic IPO — Valuation discussions reportedly falling to $1.3 trillion amid the AI regulatory selloff — private market repricing underway.
- 🟢 GOOGL/QCOM — Alphabet's $548 million Qualcomm stake signals deepening AI/data center hardware integration between the two.
- 🟡 Inflation Data Next Week — With the market on shaky ground post-rout and post-jobs beat, next week's U.S. CPI print is the next major binary risk event to watch.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/